Intelligence · Clinical Development
Pipeline search results
Programs matching “placebo” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 588 pipeline programs matching "placebo" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
NUC01, Placebo to NUC01
Dr. Falk Pharma GmbH
primary sclerosing cholangitis (PSC)
1 trial -
Niraparib Placebo Tablets
GlaxoSmithKline
Neoplasms, Breast
1 trial -
NiuBangZi pill or NiuBangZi pill placebo
Universal Integrated
Niu Bang Zi Pill
1 trial -
Nomlabofusp, Placebo to Nomlabofusp
Larimar Therapeutics
Friedreich’s ataxia is the most common inherited ataxia in humans and results from a deficiency of the mitochondrial protein, FXN. Friedreich’s ataxia is a rare, progressive, multisystem disease with an incidence that is estimated to be 1:29,000, and a carrier frequency of ~1:85.
1 trial -
Olpasiran, Placebo for AMG 890
Amgen
Cardiovascular Disease
1 trial -
Orforglipron, Placebo to match LY3502970
Eli Lilly Co.
Obesity, Overweight
1 trial -
PLACEBO SOTAGLIFLOZIN, SOTAGLIFLOZIN
LEXICON PHARMACEUTICALS, INC.
Obstructive Cardiomyopathy, Hypertrophic, Non-obstructive Hypertrophic Cardiomyopathy
1 trial -
PLACEBO for amyotrophic lateral sclerosis
Istituto Gentili S.r.l.
amyotrophic lateral sclerosis
1 trial -
PRIDOPIDINE, Pridopidine placebo
Ferrer Internacional S.A.
Amyotrophic Lateral Sclerosis
1 trial -
Placebo
Novartis Pharmaceuticals
Ankylosing Spondylitis
1 trial -
Placebo
Sanofi Pasteur
Colorectal Neoplasms
1 trial -
Placebo
AbbVie
Psoriatic Arthritis
1 trial -
Placebo
GlaxoSmithKline
Infections, Papillomavirus
1 trial -
Placebo
Takeda
Lennox Gastaut Syndrome (LGS)
1 trial -
Placebo
Boehringer Ingelheim
Diabetes Mellitus, Type 2
3 trials -
Placebo
AstraZeneca
Irritable Bowel Syndrome With Constipation (IBS-C)
1 trial -
Placebo
Tobira Therapeutics
Nonalcoholic Steatohepatitis
1 trial -
Placebo
Novartis Pharmaceuticals
IC-MPGN
1 trial -
Placebo
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Erectile Dysfunction
1 trial -
Placebo
Allergan Pharmaceuticals International Limited
Gastroparesis
3 trials -
Placebo
Takeda
Male Subjects With Chronic Constipation
1 trial -
Placebo
Alnylam Netherlands B.V.
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
1 trial -
Placebo
Eli Lilly and Company
Hepatocellular Carcinoma
1 trial -
Placebo
Ono Pharmaceutical Co.,
Chronic Sinusitis
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.